Premium Trifocal IOL Comparative Analysis

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

November 17, 2021

Study Completion Date

November 17, 2021

Conditions
CataractLens OpacitiesPresbyopia
Interventions
DEVICE

POD F GF (BVI Medical), POD F (BVI Medical), Panoptix (Alcon Inc) IOL implantation

In this study, patients have already received treatment, after receiving the consent, the routinely collected pre-, intra- and postoperative data will be pseudonymized and evaluated.

Trial Locations (4)

40212

Internationale Innovative Ophthalmochirgie, Düsseldorf

48429

Augentagesklinik Rheine, Rheine

48683

Augenklinik Ahaus, Ahaus

69120

Universitäts-Augenklinik Heidelberg, Heidelberg

All Listed Sponsors
lead

Beaver-Visitec International, Inc.

INDUSTRY

NCT04875455 - Premium Trifocal IOL Comparative Analysis | Biotech Hunter | Biotech Hunter